Variation in neoadjuvant chemotherapy utilization for epithelial ovarian cancer at high volume hospitals in the United States and associated survival
Highlights • Neoadjuvant chemotherapy use varied widely, from 5 to 55%, among high volume hospitals. • Hospital level patterns of neoadjuvant chemotherapy use are associated with survival. • Hospitals with low neoadjuvant chemotherapy utilization had decreased survival.
Gespeichert in:
Veröffentlicht in: | Gynecologic oncology 2017-06, Vol.145 (3), p.500-507 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Highlights • Neoadjuvant chemotherapy use varied widely, from 5 to 55%, among high volume hospitals. • Hospital level patterns of neoadjuvant chemotherapy use are associated with survival. • Hospitals with low neoadjuvant chemotherapy utilization had decreased survival. |
---|---|
ISSN: | 0090-8258 1095-6859 |
DOI: | 10.1016/j.ygyno.2017.03.014 |